Search

Author/Creator Schecter, J.

1. P899: REAL-WORLD ASSESSMENT OF TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH LENALIDOMIDE-REFRACTORY RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE OPTUM DATABASE. (23rd June 2022)

Authors:
Dhakal, B.; Einsele, H.; Potluri, R.; Schecter, J.; Deraedt, W.; Lendvai, N.; Slaughter, A.; Lonardi, C.; Nair, S.; He, J.; Joseph, N.; Cost, P.; Valluri, S.; Yalniz, F.; Pacaud, L.; Yong, K.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
790
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE (DVD) VS BORTEZOMIB AND DEXAMETHASONE (VD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): EFFICACY AND SAFETY UPDATE (CASTOR). (June 2017)

Authors:
Lentzsch, S.; Weisel, K.; Mateos, M.V.; Hungria, V.; Munder, M.; Nooka, A.; Mark, T.; Quach, H.; Scott, E.; Lee, J.; Sonneveld, P.; Casneuf, T.; Chiu, C.; Qin, X.; Amin, H.; Thiyagarajah, P.; Schecter, J.; Qi, M.; Spencer, A.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
388
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search